Astrana Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In December 2022, Astrana’s Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $50.0 million of its shares of common stock. In February 2026, the Board of Directors increased the total authorization under the share repurchase program to $100.0 million of its shares of common stock, including the $35.9 million that remained available under the previously announced stock repurchase program. Repurchases may be made through a variety of methods, which could include open market purchases, accelerated share repurchase transactions, negotiated block transactions, 10b5-1 plans, other transactions that may be structured through investment banking institutions or privately negotiated, or a combination of the foregoing. This share repurchase program has no expiration date. The Board may suspend, modify, or discontinue the repurchase program at any time. This repurchase program does not obligate the Company to make additional repurchases at any specific time or in any specific situation. During the three months ended September 30, 2026, no shares were repurchased under the Company’s share repurchase program. As of September 30, 2026, $83.1 million remained available under the repurchase program.
The following table provides information about purchases made by the Company of the Company’s common stock during the three months ended September 30, 2026.
| Period | Total Numberof SharesPurchased (1) | Average PricePaid PerShare | Total Number ofSharesPurchased asPart of PubliclyAnnounced Plansor Programs | Approximate DollarValue of Shares ThatMay Yet BePurchased Under thePlans or Programs(in thousands) |
|---|---|---|---|---|
| July 1, 2026 to July 31, 2026 | 3,709 | $46.55 | — | $83,105 |
| August 1, 2026 to August 31, 2026(2) | 31,469 | $38.55 | — | $83,105 |
| September 1, 2026 to September 30, 2026 | 31,805 | $38.33 | — | $83,105 |
| Total | 66,983 | $38.89 | — | $83,105 |
(1)
Includes 38,483 shares repurchased to satisfy tax withholding obligations due upon the vesting of restricted stock awards held by certain employees. We did not pay cash to repurchase these shares, nor were these repurchases part of a publicly announced plan or program.
(2)
Includes 28,500 shares of common stock repurchased from two members of the Board of Directors during August 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.